Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 3
This trial is looking at the combination of pembrolizumab and paclitaxel with or without bevacizumab. It is for women whose cancer has come back after having chemotherapy that included a .
The trial is for women who have:
These cancers are similar and the treatments are the same. In this summary when we use ovarian cancer we are referring to all 3 cancers.
Recruitment start: 21 March 2022
Recruitment end: 6 August 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Emma Hudson
Merck Sharp & Dohme Ltd
Last reviewed: 21 December 2023
CRUK internal database number: 18961
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
